Resultados de la búsqueda 1091-1100 of 8811 for Ureaplasma urealyticum

  1. Mayo Clinic

    Share · Tweet. April 20, 2024. Ver también. Absceso dental · Agammaglobulinemia ligada al cromosoma X · Anafilaxia · Anorgasmia en mujeres · Asma infantil ...

  2. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the short-term outcomes and the quality of life (QOL) after cholecystectomy and hepatic artery infusion pump placement ...

  5. Oncología (médica) - Ensayos clínicos

    The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the registry will be to support ongoing ...

  6. Oncología (médica) - Ensayos clínicos

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Currently, only a few international institutions use CIRT to treat pelvic bone sarcomas. Accordingly, data evaluating the potential differences in ...

  8. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen ...

  9. Oncología (médica) - Ensayos clínicos

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...